IVP · As filed with the SEC
Inspire Veterinary Partners balance sheet, by quarter
The statement as Inspire Veterinary Partners presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Unaudited Condensed Consolidated Balance Sheets · USD
| USD | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Jun 30, 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | — | — | — | 523,690 | 681,199 | — | 69,077 | 178,961 |
| Cash and cash equivalents | 341,746 | 158,942 | 1,738,033 | — | — | — | — | — |
| Accounts receivable, net | 28,704 | 183,634 | 4,376 | 40,675 | 115,551 | — | 341,488 | 28,573 |
| Due from former owners | — | — | — | — | — | — | — | 32,519 |
| Inventory | 497,614 | 476,991 | 475,152 | 516,650 | 563,595 | — | 545,660 | 571,512 |
| Refundable income tax | — | — | — | — | — | — | 151,796 | 151,796 |
| Investments – equity securities | 2,571,429 | — | — | — | — | — | — | — |
| Prepaid expenses and other current assets | 385,055 | 513,647 | 683,687 | 942,456 | 3,090,371 | — | 2,031,311 | 388,759 |
| Total current assets | 3,824,548 | 1,333,214 | 2,901,248 | 2,023,471 | 4,450,716 | — | 3,139,332 | 1,352,120 |
| Restricted cash - non-current | 234,500 | 234,500 | 120,000 | 200,000 | 200,000 | — | 200,000 | 200,000 |
| Property and equipment, net | 6,889,958 | 7,025,647 | 6,280,246 | 6,382,788 | 6,486,444 | — | 7,966,721 | 7,949,144 |
| Right-of-use assets | 1,695,171 | 1,748,589 | 1,802,006 | 1,879,729 | 1,347,026 | — | 1,562,367 | 1,616,198 |
| Intangibles assets | 1,175,099 | 1,426,446 | 1,481,352 | 1,633,927 | 1,864,355 | — | 2,305,014 | 2,513,028 |
| Goodwill | 9,088,263 | 8,988,263 | 8,022,082 | 8,022,082 | 8,022,082 | — | 8,147,590 | 8,147,590 |
| Deferred financing costs | 1,000,000 | — | — | — | — | — | — | — |
| Other assets | 48,227 | 53,997 | 53,997 | 53,997 | 25,115 | — | 73,989 | 12,895 |
| Total assets | 23,955,766 | 20,810,656 | 20,660,931 | 20,195,994 | 22,395,738 | — | 23,395,013 | 21,790,975 |
| Liabilities and Stockholder’s Deficit | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | 1,700,265 | 1,875,438 | 1,769,991 | 1,979,503 | 2,073,582 | — | 3,521,759 | 3,206,594 |
| Accrued expenses | 969,940 | 1,013,364 | 643,311 | 285,770 | 305,118 | — | 455,227 | 858,334 |
| Cumulative Series A preferred stock dividends payable | — | — | — | — | — | — | 2,250 | 92,322 |
| Operating lease liabilities | 170,774 | 166,945 | 163,193 | 183,981 | 164,107 | — | 133,113 | 141,691 |
| Loan payable, net of discount | — | — | — | — | — | — | — | 1,713,831 |
| Loans payable, net of discount | 2,057,740 | 2,738,871 | 1,737,846 | 2,340,020 | 2,233,004 | — | 2,338,067 | — |
| Convertible debentures, net of issuance costs | — | — | — | — | — | — | — | 100,000 |
| Notes payable, net of discount | — | — | — | — | — | — | — | 1,469,043 |
| Convertible notes payable | 274,908 | 258,393 | — | — | 850,000 | — | 500,000 | — |
| Promissory note | 1,120,623 | 511,682 | — | — | — | — | — | — |
| Notes payable, net of discount | — | 3,486,268 | 3,157,641 | 3,410,465 | 1,401,449 | — | 1,501,562 | — |
| Notes payable, net of discount | 3,424,599 | — | — | — | — | — | — | — |
| Total current liabilities | 9,718,849 | 10,050,961 | 7,471,982 | 8,199,739 | 7,027,260 | — | 8,451,978 | 7,581,815 |
| Operating lease liabilities, non-current | 1,813,828 | 1,857,960 | 1,901,083 | 1,943,487 | 1,417,372 | — | 1,482,514 | 1,514,044 |
| Notes payable - noncurrent | 8,254,408 | 8,455,473 | 8,283,910 | 8,490,763 | 10,921,103 | — | 13,190,668 | 13,483,375 |
| Total liabilities | 19,787,085 | 20,364,394 | 17,656,975 | 18,633,989 | 19,365,735 | — | 23,125,160 | 22,579,234 |
| Stockholder’s Equity (Deficit) | ||||||||
| Class A | 360 | 231 | 211 | 117 | 1,336 | — | 74 | 705 |
| Class B | 302 | 302 | 302 | 302 | 389 | — | 389 | 389 |
| Convertible Series A | — | — | — | — | — | — | 8 | 40 |
| Convertible Series B | 1 | — | — | — | — | — | — | — |
| Additional paid in capital | 48,494,176 | 42,245,614 | 41,768,760 | 37,911,867 | 34,761,924 | — | 25,118,701 | 20,425,864 |
| Accumulated deficit | (44,326,158) | (41,799,885) | (38,765,317) | (36,350,281) | (31,733,646) | — | (24,849,319) | (21,215,257) |
| Total stockholder’s equity (deficit) | 4,168,681 | 446,262 | 3,003,956 | 1,562,005 | 3,030,003 | — | 269,853 | (788,259) |
| Total liabilities and stockholder’s equity (deficit) | 23,955,766 | 20,810,656 | 20,660,931 | 20,195,994 | 22,395,738 | — | 23,395,013 | 21,790,975 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.
Data on this page was fetched . The filing on SEC.gov is the record.